Cours SMITH & NEPHEW Swiss Exchange
Actions
SN.
GB0009223206
Equipement, fournitures et distribution médicale
Cours en clôture
Autres places de cotation
|
||
- GBX | - |
|
CA 2024 * | 5,81 Md 5,2 Md | CA 2025 * | 6,12 Md 5,48 Md | Capitalisation | 11,8 Md 10,57 Md |
---|---|---|---|---|---|
Résultat net 2024 * | 526 M 471 M | Résultat net 2025 * | 687 M 615 M | VE / CA 2024 * | 2,48 x |
Dette nette 2024 * | 2,61 Md 2,34 Md | Dette nette 2025 * | 2,3 Md 2,06 Md | VE / CA 2025 * | 2,3 x |
PER 2024 * |
21,3
x | PER 2025 * |
16,1
x | Employés | - |
Rendement 2024 * |
2,76% | Rendement 2025 * |
3,09% | Flottant | 99,15% |
Dernier transcript sur SMITH & NEPHEW
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Deepak Nath
CEO | Chief Executive Officer | - | 01/04/22 |
John Rogers
DFI | Director of Finance/CFO | 56 | 01/12 |
Alison Parkes
CMP | Compliance Officer | - | 01/04/99 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Marc E. Owen
BRD | Director/Board Member | 65 | 01/10/17 |
Jeremy Maiden
BRD | Director/Board Member | 62 | 14/09/23 |
Rupert Soames
CHM | Chairman | 63 | 26/04/23 |
Nom | PEA | Position | Varia. 1 janv. | Notation |
---|---|---|---|---|
SCHRODER ISF UK EQUITY A ACC GBP | Non | 2.57M GBP | +7,00% | |
WELLINGTON FOCUSED EUROPEAN EQ EUR S AC | Non | 0.08M EUR | +20,00% | |
AAF-EDENTREE EUROPEAN SUST EQS A | Non | 18.95M EUR | +13,00% |
Varia. 1 janv. | Capi. | |
---|---|---|
+12,62% | 128 Md | |
+53,19% | 6,65 Md | |
-23,60% | 6,65 Md | |
-30,75% | 4,19 Md | |
-19,96% | 2,46 Md | |
-17,14% | 1,94 Md | |
-21,05% | 1,75 Md | |
-37,13% | 1,45 Md | |
-16,31% | 1,06 Md |
- Bourse
- Actions
- Action SN.
- Action SN.